A NON-INTERVENTIONAL STUDY ON AVELUMAB USE IN PATIENTS WITH ADVANCED OR METASTATIC UROTHELIAL CARCINOMA
NCT ID: NCT04822350
Last Updated: 2025-01-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
599 participants
OBSERVATIONAL
2021-07-13
2024-04-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy
NCT05366725
A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100)
NCT02603432
A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer
NCT03498196
Avelumab Plus Carboplatin-gemcitabine in Urothelial Carcinoma
NCT03390595
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
NCT00461851
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Locally advanced or metastatic urothelial carcinoma patients treated with avelumab
Avelumab
As provided in real world practice
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Avelumab
As provided in real world practice
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient with locally advanced or metastatic urothelial carcinoma (irrespective of tumor histology) whose disease has not progressed (ongoing stable disease, partial response or complete response) following completion of first-line platinum-based chemotherapy and who has been (retrospective), is (retrospective and prospective), will be (prospective) treated with avelumab.
* For a patient alive at the moment of the inclusion in the study : the patient must be informed of the study, he/she must be given an information letter signed by the investigator and must not be opposed to the collection of his/her data
* For a patient who died before the inclusion in the study : the patient (during his life time) must not be opposed in writing to the collection of his data.
3. Patient benefiting from a social security scheme according to local regulations
Exclusion Criteria
5. Patient enrolled in a prospective interventional clinical trial assessing an investigational product.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Merck KGaA, Darmstadt, Germany
INDUSTRY
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Charles Nicolle
Rouen, Haute-normandie, France
CHU Nantes
Nantes, Pays de la Loire Region, France
Centre Hospitalier du Pays d AIX
Aix-en-Provence, , France
CHU Amiens-Picardie
Amiens, , France
Centre Hospitalier Victor Dupouy
Argenteuil, , France
Centre Hospitalier Auxerre
Auxerre, , France
Institut Sainte Catherine
Avignon, , France
Centre Hospitalier de la cote Basque
Bayonne, , France
Chru Besancon
Besançon, , France
Clinique Tivoli-Ducos
Bordeaux, , France
CHU de Bordeaux - Hopital Saint Andre
Bordeaux, , France
Institut Bergonie
Bordeaux, , France
Centre Hospitalier de Boulogne Sur Mer
Boulogne-sur-Mer, , France
Centre Hospitalier Regional Universitaire de Brest
Brest, , France
Clinique Pasteur - Lanroze
Brest, , France
Hopital Louis Pradel
Bron, , France
CENTRE HOSPITALIER Dr Jean-Eric TECHER
Calais, , France
Medipole de Savoie
Challes-les-Eaux, , France
Centre de Lutte Contre Le Cancer - Auvergne Jean Perrin
Clermont-Ferrand, , France
Centre Hospitalier Universitaire Gabriel Montpied
Clermont-Ferrand, , France
Pole Sante Republique
Clermont-Ferrand, , France
Polyclinique Saint Come
Compiègne, , France
Clinique de Flandre
Coudekerque-Branche, , France
Centre Hospitalier Intercommunal de Creteil
Créteil, , France
Centre Leonard de Vinci
Dechy, , France
Clinique Clement Drevon
Dijon, , France
Centre Hospitalier Intercommunal Louviers
Elbeuf, , France
Centre Hospitalier Annecy Genevois
Epargny METZ Tessy, , France
Clinique Du Mousseau
Évry, , France
Chi Frejus - Saint Raphael
Fréjus, , France
Chi Alpes Du Sud
Gap, , France
Centre Hospitalier de Grenoble
Greboble, , France
Groupe Hospitalier Mutualiste de Grenoble Institut Daniel Hollard
Grenoble, , France
Centre Hospitalier Haguenau
Haguenau, , France
Polyclinique de Blois
La Chaussée-Saint-Victor, , France
La Roche Sur Yon - Centre Hospitalier Departemetal Vendee
La Roche-sur-Yon, , France
Groupe Hospitalier La Rochelle - Re - Aunis
La Rochelle, , France
Clinique Victor Hugo
Le Mans, , France
Centre Hospitalier Emile Roux
Le Puy-en-Velay, , France
Polyclinique Du Bois
Lille, , France
Clinique de la Louvière
Lille, , France
Chu Dupuytren Service Oncologie
Limoges, , France
Polyclinique de LIMOGE-Clinique François CHENIEUX
Limoges, , France
Centre Hospitalier Jura Sud
Lons-le-Saunier, , France
Centre Hospitalier Bretagne Sud
Lorient, , France
Clinique de la Sauvegarde
Lyon, , France
Centre Leon Berard
Lyon, , France
Hopital Europeen
Marseille, , France
Hopital de La Timone
Marseille, , France
Centre Hospitalier Universitaire de Montpellier
Montpellier, , France
Hopital prive Arnault Tzanck
Mougins, , France
Centre D'Oncologie de Gentilly
Nancy, , France
Hopital prive du Confluent S.A.S
Nantes, , France
Clinique Saint Georges
Nice, , France
Centre Antoine Lacassagne
Nice, , France
Institut de Cancerologie Du Gard
Nîmes, , France
ONCOGARD
Nîmes, , France
Hopital Prive Sainte Marie
Osny, , France
Hopital Saint-Louis
Paris, , France
Hopital Pitie Salpetriere
Paris, , France
Hopital Cochin/Unité de Cancerologie
Paris, , France
Groupe Hospitalier Diaconesse La Croix Saint Simon
Paris, , France
Hopital Europeen Georges Pompidou
Paris, , France
Polyclinique Marzet
Pau, , France
Centre Hospitalier de Cornouaille
Quimper, , France
Institut Jean Godinot
Reims, , France
Centre Hopistalier Roanne
Roanne, , France
Ch Roubais
Roubaix, , France
Clinique Mathilde
Rouen, , France
Centre Hospitalier Prive Saint Gregoire
Saint-Grégoire, , France
Hia Begin
Saint-Mandé, , France
Clinique mutualiste de l Estuaire
Saint-Nazaire, , France
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, , France
Centre Hospitalier de Soissons
Soissons, , France
Clinique Sainte Anne
Strasbourg, , France
ICANS - Institut de cancerologie Strasbourg Europe
Strasbourg, , France
Hopital Foch
Suresnes, , France
Hia Sainte Anne
Toulon, , France
IUCT - Oncopole
Toulouse, , France
Centre Alexis VAUTRIN
Vandœuvre-lès-Nancy, , France
Institut Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCT04822350
Identifier Type: REGISTRY
Identifier Source: secondary_id
B9991045
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.